Obstacles and solutions for worldwide implementation of the Molecular Endometrial Carcinoma Classification-Recording

Video Transcription

Video Summary

The video summary is as follows: In the video, Dr. Charlene Bosse discusses the molecular classification of endometrial cancer. She highlights the importance of testing for specific genetic mutations, including POLE, MMR, and P53, which can provide valuable prognostic information and guide treatment decisions. Dr. Bosse also addresses obstacles to implementing the molecular classification, such as limited resources and costs, and suggests possible solutions, including cheaper testing alternatives and the use of artificial intelligence. She emphasizes the need for widespread adoption of the molecular classification to improve patient outcomes and suggests that the cost savings from treatment de-escalation can help cover the costs of testing. In conclusion, Dr. Bosse advocates for the implementation of the molecular classification in endometrial cancer to improve risk stratification and personalize treatment approaches.

Keywords

molecular classification

endometrial cancer

genetic mutations

prognostic information

treatment decisions

obstacles

costs

solutions

personalize treatment approaches